Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21041705

Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Dec 10
First author
Sloand EM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2011 Dec 20;29(36):4841-2; author reply 4842. doi: 10.1200/JCO.2011.38.4602.
    note
    Source null
    related pmid
    22084365
    relationship
    Comment in

Authors and identifiers

  1. name
    Sloand EM
    type
    Author
  2. name
    Olnes MJ
    type
    Author
  3. name
    Shenoy A
    type
    Author
  4. name
    Weinstein B
    type
    Author
  5. name
    Boss C
    type
    Author
  6. name
    Loeliger K
    type
    Author
  7. name
    Wu CO
    type
    Author
  8. name
    More K
    type
    Author
  9. name
    Barrett AJ
    type
    Author
  10. name
    Scheinberg P
    type
    Author
  11. name
    Young NS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sloand EM
    type
    Author
  2. name
    Olnes MJ
    type
    Author
  3. name
    Shenoy A
    type
    Author
  4. name
    Weinstein B
    type
    Author
  5. name
    Boss C
    type
    Author
  6. name
    Loeliger K
    type
    Author
  7. name
    Wu CO
    type
    Author
  8. name
    More K
    type
    Author
  9. name
    Barrett AJ
    type
    Author
  10. name
    Scheinberg P
    type
    Author
  11. name
    Young NS
    type
    Author
bibliography ids
  1. nci-bib-07765be524e06acab42755ac
book metadata
content sha256
a4c62190b12189bfb4b8fd87b73569fc36720d8042e00c05ae339d88732ddcbe
document type
citation
dois
  1. 10.1200/JCO.2010.29.7010
electronic publication date
display
2010 Nov 1
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:21041705
immutable id
pubmed:21041705@a4c62190b12189bfb4b8fd87b73569fc36720d8042e00c05ae339d88732ddcbe
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
35
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
5166-73
volume
28
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2011 Dec 20;29(36):4841-2; author reply 4842. doi: 10.1200/JCO.2011.38.4602.
    note
    Source null
    related pmid
    22084365
    relationship
    Comment in
outcomes validated
false
pmid
21041705
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
797dec0adbf694505897c81a3cc1c91666a81b1945020c2c484a7708c6bce583
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Dec 10
precision
day
year
2010
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Research Support, N.I.H., Intramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21041705/
title
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.

Preserved source evidence · Not medical advice